Rock Springs Capital Management LP Q2 2022 Filing
Filed August 15, 2022
Portfolio Value
$3.4B
Holdings
131
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (131 positions)
| Stock | Value |
|---|---|
HUMHUMANA INC | $199.6M |
AGLAGILON HEALTH INC | $167.7M |
UNHUNITEDHEALTH GROUP INC | $137.9M |
ARGXARGENX SE | $132.6M |
NBIXNEUROCRINE BIOSCIENCES INC | $109.4M |
PODDINSULET CORP | $109.4M |
IMCRIMMUNOCORE HLDGS PLC | $99.7M |
EVHEVOLENT HEALTH INC | $84.1M |
AFWALIGN TECHNOLOGY INC | $83.9M |
IDXXIDEXX LABS INC | $78.5M |
RAREULTRAGENYX PHARMACEUTICAL IN | $65.2M |
AGIOAGIOS PHARMACEUTICALS INC | $64.9M |
—SIERRA ONCOLOGY INC | $64.6M |
ISRGINTUITIVE SURGICAL INC | $59.9M |
HZNPHORIZON THERAPEUTICS PUB L | $59.5M |
PCRXPACIRA BIOSCIENCES INC | $59.3M |
EWEDWARDS LIFESCIENCES CORP | $57.2M |
MRTXEURMIRATI THERAPEUTICS INC | $56.7M |
KRTXKARUNA THERAPEUTICS INC | $55.9M |
ACRSACLARIS THERAPEUTICS INC | $54.8M |
ACHCACADIA HEALTHCARE COMPANY IN | $51.0M |
PENPENUMBRA INC | $50.0M |
2L9BLUEPRINT MEDICINES CORP | $49.5M |
ALNYALNYLAM PHARMACEUTICALS INC | $48.5M |
SGENUSDSEAGEN INC | $48.1M |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $46.7M |
SWAVUSDSHOCKWAVE MED INC | $46.0M |
BAXBAXTER INTL INC | $45.1M |
ZLABZAI LAB LTD | $42.2M |
ASNDASCENDIS PHARMA A/S | $39.6M |
DC4DEXCOM INC | $35.2M |
CVETUSDCOVETRUS INC | $34.8M |
XENEXENON PHARMACEUTICALS INC | $34.2M |
NVROEURNEVRO CORP | $33.9M |
WSTWEST PHARMACEUTICAL SVSC INC | $33.6M |
MIRMMIRUM PHARMACEUTICALS INC | $33.4M |
FRPTFRESHPET INC | $33.1M |
PHRPHREESIA INC | $32.5M |
SRPTSAREPTA THERAPEUTICS INC | $32.1M |
IRTCIRHYTHM TECHNOLOGIES INC | $29.2M |
XLVSELECT SECTOR SPDR TR | $25.6M |
NVV1NOVAVAX INC | $24.4M |
—ABCAM PLC | $23.4M |
TVTXTRAVERE THERAPEUTICS INC | $23.1M |
MDGLMADRIGAL PHARMACEUTICALS INC | $22.7M |
EXASEXACT SCIENCES CORP | $22.6M |
BMRNBIOMARIN PHARMACEUTICAL INC | $21.9M |
CNMDCONMED CORP | $21.4M |
DVAXDYNAVAX TECHNOLOGIES CORP | $21.2M |
—TURNING POINT THERAPEUTICS I | $20.5M |
LEGNLEGEND BIOTECH CORP | $19.6M |
—CINCOR PHARMA INC | $19.2M |
—MERSANA THERAPEUTICS INC | $18.8M |
AMLXAMYLYX PHARMACEUTICALS INC | $18.8M |
—OLINK HLDG AB | $18.7M |
PRTAPROTHENA CORP PLC | $18.4M |
—PROMETHEUS BIOSCIENCES INC | $18.2M |
ACCDEURACCOLADE INC | $16.3M |
CYTKCYTOKINETICS INC | $15.7M |
BCRXBIOCRYST PHARMACEUTICALS INC | $15.5M |
KYMRKYMERA THERAPEUTICS INC | $15.3M |
WRBYWARBY PARKER INC | $14.3M |
AURAAURA BIOSCIENCES INC | $14.3M |
CMPXCOMPASS THERAPEUTICS INC | $14.1M |
HCATHEALTH CATALYST INC | $13.7M |
BMEABIOMEA FUSION INC | $13.0M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $12.8M |
INZYINOZYME PHARMA INC | $12.6M |
NVCRNOVOCURE LTD | $12.2M |
ARVNARVINAS INC | $11.8M |
AZTAAZENTA INC | $11.7M |
ANABANAPTYSBIO INC | $11.6M |
LFSTLIFESTANCE HEALTH GROUP INC | $11.1M |
—EPIZYME INC | $11.0M |
AM6AMICUS THERAPEUTICS INC | $10.9M |
RLAYRELAY THERAPEUTICS INC | $10.4M |
LUNGPULMONX CORP | $10.3M |
IMTXIMMATICS N.V | $9.8M |
—ORION ACQUISITION CORP | $9.8M |
—AMRYT PHARMA PLC | $9.2M |
TCE2CELLDEX THERAPEUTICS INC NEW | $9.0M |
290ACHINOOK THERAPEUTICS INC | $8.9M |
NVTA1EURINVITAE CORP | $8.5M |
AUPHAURINIA PHARMACEUTICALS INC | $8.2M |
GHGUARDANT HEALTH INC | $8.1M |
—KINNATE BIOPHARMA INC | $7.8M |
VERVVERVE THERAPEUTICS INC | $7.7M |
NKTXNKARTA INC | $7.6M |
GOSS 5 06/01/27GOSSAMER BIO INC | $7.2M |
MREOMEREO BIOPHARMA GROUP PLC | $7.0M |
DSGNDESIGN THERAPEUTICS INC | $6.4M |
AKROAKERO THERAPEUTICS INC | $6.4M |
EDAEDAP TMS S A | $6.2M |
RYTMRHYTHM PHARMACEUTICALS INC | $5.8M |
—F-STAR THERAPEUTICS INC | $4.7M |
—EQRX INC | $4.7M |
—ICOSAVAX INC | $4.4M |
BEAMBEAM THERAPEUTICS INC | $4.3M |
LPTXEURLEAP THERAPEUTICS INC | $4.2M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $4.0M |
Page 1 of 2Next